Home Page: JTO Clinical and Research Reports

Articles in Press

Full length article
Open Access
Effects of Ethnicity on Outcomes of Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) Treated with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKI) and Surgical Resection
Published online: December 4, 2021
Full length article
Open Access
Life-Threatening Myositis in a Patient with EGFR-mutated NSCLC on Osimertinib: case report
Published online: December 4, 2021
Full length article
Open Access
Clinical Characteristics and Outcomes in Advanced KRAS-mutated NSCLC: a multi-center collaboration in Asia (ATORG-005)
Published online: December 4, 2021
Full length article
Open Access
A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With Non-Small Cell Lung Cancer
Published online: December 4, 2021

About

Cover Image - JTO Clinical and Research Reports, Volume 2, Issue 11

JTO Clinical and Research Reports is the official open access journal of the International Association for the Study of Lung Cancer. It aims to complement the Journal of Thoracic Oncology by offering authors a gold open access publication option and publishing the following article types in particular: Phase I trials, Well performed single-arm phase II trials, More

Cover Image - Journal of Thoracic Oncology, Volume 16, Issue 12

Subscribe to Journal

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 8,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide.

Masthead

Current Issue Links

Submit Mobile

Articles in Press

Effects of Ethnicity on Outcomes of Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) Treated with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKI) and Surgical Resection

Life-Threatening Myositis in a Patient with EGFR-mutated NSCLC on Osimertinib: case report

Clinical Characteristics and Outcomes in Advanced KRAS-mutated NSCLC: a multi-center collaboration in Asia (ATORG-005)

A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With Non-Small Cell Lung Cancer

Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLC

Cardiac Safety Assessment of Lazertinib: Findings From Patients With EGFR Mutation-Positive Advanced NSCLC and Preclinical Studies

Pembrolizumab Plus Chemotherapy for Chinese Patients With Metastatic Squamous NSCLC in KEYNOTE-407

Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors

Most Read (Last 30 Days)

Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients with Lung Adenocarcinoma after Complete Resection: Results From the ICAN Study

Response to icotinib plus chemotherapy in pulmonary atypical carcinoid harboring the EGFR L858R mutation: a brief report

MET Amplification and Efficacy of Nivolumab in Patients With NSCLC

Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report

CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis

Obesity-Specific Association of Statin Use and Reduced Risk of Recurrence of Early Stage NSCLC

Catalog of 5′ fusion partners in RET+ NSCLC Circa 2020

A Catalog of 5’ Fusion Partners in ROS1-Positive NSCLC Circa 2020

EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors

Ultrarapid EGFR Mutation Screening Followed by Comprehensive Next-Generation Sequencing: A Feasible, Informative Approach for Lung Carcinoma Cytology Specimens With a High Success Rate

Preclinical Characterization of Mobocertinib Highlights the Putative Therapeutic Window of This Novel EGFR Inhibitor to EGFR Exon 20 Insertion Mutations

Masthead

Current Issue Links

Submit Mobile

Explore

Publish

Connect

Articles in Press

Issue Highlights

About

JTO Clinical and Research Reports

Companion Journal

About the Society

Most Read (Last 30 Days)

Most Cited (Previous 3 Years)